Optical coherence tomography and its recent applications for three-dimensional imaging of organoids

Article information

Organoid. 2024;4.e7
Publication date (electronic) : 2024 July 25
doi : https://doi.org/10.51335/organoid.2024.4.e7
1School of Electrical and Electronics Engineering, College of ICT Engineering, Chung-Ang University, Seoul, Korea
2Department of Intelligent Semiconductor Engineering, Chung-Ang University, Seoul, Korea
3Department of Physics, Chosun University, Gwangju, Korea
Correspondence to: Woo June Choi, PhD School of Electrical and Electronics Engineering, College of ICT Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea E-mail: cecc78@cau.ac.kr
Received 2024 February 16; Revised 2024 July 4; Accepted 2024 July 10.

Abstract

An organoid is a self-organizing, miniaturized model of an organ that recapitulates the architecture and physiology of the tissue of origin. With their high resemblance to the structure and function of real organs, organoids have shown enormous potential for studying organ development and growth, as well as modeling diseases in vitro. In organoid studies, optical coherence tomography (OCT), a coherence-based imaging technology, has garnered significant attention as an emerging tool for 3-dimensional organoid imaging. This modality enables the direct observation and monitoring of organoid structure and intercellular events at micrometer-scale resolution and millimeter-scale imaging depth, encompassing the entire body of the organoid. In this paper, we introduce the applications of OCT to recent organoid research, outlining several studies on OCT for the structural and functional imaging of different types of organoids. This review aims to inform bioengineers involved in biomedicine about OCT technologies that could be beneficial for their organoid research.

Introduction

An organoid is an in vitro 3-dimensional (3D) cellular tissue designed to closely mimic the structural, functional, and biological complexity of an organ in vivo [13]. These miniature organs are grown from stem cells, such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and somatic cells derived from human tissue. Derived from stem cells with self-renewal and differentiation capacities, organoids can self-assemble in 3D culture and, more importantly, can be readily differentiated into a wide range of organ types [46]. Compared to traditional 2-dimensional (2D) monolayer cell cultures, these self-organized 3D organoid cultures more closely resemble both the microarchitecture and functionality of native organs [7]. Furthermore, they are much more amenable to the manipulation of niche components, signaling pathways, and genome editing than in vivo models [8]. Due to their high similarity to organs and ease of manipulation, these 3D microtissues have received substantial interest as alternative models for improved human tissue modeling. With ongoing advancements in stem cell and organoid cultivation technologies [9], organoids have been successfully established for a multitude of organs in the human body, including but not limited to the liver, lung, brain, kidney, stomach, gut, retina, and intestine [10,11]. As a result, various types of organoids have been extensively utilized in biomedical fields to advance studies in tissue development, disease modeling, drug discovery, personalized medicine, regenerative medicine, precision medicine, and cell therapy [12,13].

Understanding the intricate morphology and physiology of organoids requires the integration of various imaging modalities. Optical imaging technologies are particularly effective for studying organoids, as they enable the visualization of the interiors of light-translucent organoids. Bright-field microscopy, a widely used live cell microscopy technique, is routinely employed to assess the overall shape of an organoid and its cellular compartments [14,15]. Epi-fluorescence microscopy, a type of wide-field microscopy used for fluorescence imaging, can visualize specific organelles, biomolecules, and gene expression patterns in an organoid, especially with the introduction of fluorescent probes or markers [16]. However, these traditional microscopy techniques are limited to 2D tissue-sectioning imaging, which is not ideal for visualizing the cellular complexity of biological specimens like organoids. For this reason, 3D imaging is crucial to understanding the cellular composition, cell shape, cell-fate decisions, and cell-cell interactions within intact organoids.

Non-invasive optical sectioning microscopic techniques, such as confocal microscopy and light-sheet microscopy, enable the visualization of fine cellular details within an organoid. Confocal microscopy, the most widely used modality for organoid imaging [17], generates optical sections by focusing a scanning laser beam on specific sample layers. A pinhole in front of the detector allows the passage of in-focus fluorescence signals, while blocking most scattered light out of focus, thus yielding depth images free from background noise [18]. Light-sheet microscopy, which has been gaining favor for 3D organoid imaging [19,20], differs from point scanning techniques. It generates a thin excitation laser sheet that illuminates the organoid from the side. This lateral illumination excites only the fluorophores within the narrow beam slab, emitting fluorescence signals, while the samples above and below the slab remain unaffected. Depth-resolved imaging is achieved by axially shifting either the light sheet or the sample itself. These microscopy techniques enable high-resolution imaging of the entire organoid, thus aiding in the 3D characterization of a wide range of organoids at the single-cell level [17]. However, longitudinal imaging with fluorescence microscopy may be hindered by photobleaching, a photochemical alteration of a fluorophore molecule that occurs as it repeatedly undergoes the fluorescence process. When a fluorescent sample is photobleached, the fluorophores no longer become excited, even when the required light energy is supplied, leading to an irreversible loss of fluorescence [21]. Therefore, this photobleaching effect may limit the image quality of these microscopic techniques and reduce the statistical accuracy in organoid detection.

In recent years, optical coherence tomography (OCT) has gained considerable attention as a newly emerging tool for 3D imaging of organoids. OCT is a well-established imaging technology that utilizes low-coherent light interferometry to detect light signals scattered from translucent or opaque materials [22,23]. OCT possesses unique imaging capabilities, allowing non-invasive, depth-resolved cross-sectional imaging of highly scattered samples at a micrometer-scale (1–10 μm) image resolution and a penetration depth of a few millimeters (1–3 mm) [24,25]. Unlike confocal and light-sheet microscopies, which typically involve a trade-off between imaging resolution and depth, OCT can achieve both simultaneously. This feature is particularly beneficial for visualizing the cellular details of large culture systems or tissues thicker than a few hundred microns. Additionally, OCT does not require the use of contrast agents (e.g., fluorophores) or sample holders for mounting, which simplifies the imaging process by eliminating the need for complex sample preparations and concerns about photobleaching. It allows for imaging of the sample in its intact state. These label-free and straightforward characteristics of OCT enable continuous imaging of the same sample in its vital condition over extended periods, ranging from a few days to months [26,27]. Due to its advantages in imaging—namely, (1) live sub-surface images at microscopic resolution, (2) no preparation of the sample and no contact, and (3) no ionizing radiation—OCT has revolutionized 3D live cell and tissue imaging over the past 3 decades. This has been particularly impactful in biomedical research and clinical practice [28], and now, OCT is emerging as a hot topic within the organoid community.

In this review, we provide an overview of the recent applications of OCT in basic and translational organoid research. OCT has been utilized to image and analyze several types of 3D organoids in culture. The aim of this review is to inform bioengineers involved in biomedicine about the OCT technologies that could be beneficial for their organoid research.

Basic theory of OCT

Ethics statement: This study was a literature review of previously published studies and was therefore exempt from institutional review board approval.

1) Principles of OCT

The working mechanism of OCT is akin to ultrasound (US) imaging [29,30]. In both techniques, waves are transmitted to the tissue under examination—light waves in the case of OCT and acoustic waves for US. These waves echo off the tissue structures, and the back-reflected waves from the tissue layers, which are interfaces between structures of different refractive indices, are detected. The echo delay is then measured to determine the depth at which the reflection occurred. Since OCT uses light waves, which travel significantly faster (i.e., 2×105 times greater) than sound waves used in US, it is impossible to directly detect the train of back-reflected light with current photo-receivers, as they cannot resolve the very short time intervals between them. Instead, OCT utilizes a technique known as low-coherence optical interferometry, which is fundamental to all OCT implementations [29,30]. Optical interferometry is a method that uses the interference created by the superposition of 2 light waves with identical optical properties (e.g., amplitude and polarization), originating from the same light source. This technique is characterized by a coherence length, which is the physical distance over which interference is maintained. In OCT interferometry, the coherence length is only a few micrometers, due to the broad spectral bandwidth of the light source. This means that interference is observed only within a range of a few micrometers. Interference occurs only if the difference in the travel distances (optical path lengths) of the 2 light waves is within this short coherence length. Light that travels outside the coherence length will not interfere. Therefore, in a multi-layered sample with light transparency, it can be deduced that interferometry with low coherence can resolve interferences only if the optical paths are matched in length within the coherence length. This phenomenon of generating interference within the coherence limit is known as coherence gating [29,30].

2) Technical implementation of OCT

OCT technology is implemented using low-coherence interferometers, which are categorized into 2 types based on the method of interference signal acquisition: time-domain OCT (TD-OCT) and Fourier-domain OCT (FD-OCT). TD-OCT represents the initial application of OCT technology, and Fig. 1 illustrates a typical schematic of a fiber-based TD-OCT system [31]. As shown in Fig. 1, an output beam from a broadband light source (40–100 nm at full width at half-maximum [FWHM] in spectrum) is split into 2 equal beams by a fiber coupler, directed to a reference arm and a sample arm, respectively. The light waves that are retro-reflected from the surface of the reference reflector (a reference mirror) and back-reflected from a sample (a human eye) are recombined at the fiber coupler, generating interference under the conditions described above. The resulting interference signal is detected by a photodetector, which converts the optical signal into an electrical signal. If the reference reflector is displaced in the depth (z) direction as shown in Fig. 1, the optical path length (OPL) of the reference arm is modulated, and then the coherence gate is temporally positioned inside the sample. The single axial (z) movement of the reference reflector generates a series of interferometric signals contributed by the internal layers of the sample in depth, and these are consecutively recorded by the photodetector (U). The envelopes of the recorded interference signal intensities are extracted via post-signal processing (A), representing the reflectivity at each sample layer. Therefore, the depth profile of the sample reflectivity values provides structural information on the sample at the beam position. This depth-scanned reflectivity profile is referred to as an A-scan.

Fig. 1.

The working principle of time-domain optical coherence tomography is as follows: light from the source is split into a reference beam and a sample beam. The light that is back-reflected from both arms is recombined and recorded by the photodetector. To record one depth profile of the sample (A-scan), the reference arm needs to be axially scanned. This procedure must be repeated for each lateral scan position.

Furthermore, the sample beam is laterally scanned in the x-direction using a mechanical scanner, while the reference reflector is scanned in the depth (z) direction, collecting A-scans from different beam positions. This collection of A-scans, also known as a B-scan, forms a cross-sectional (x-z) OCT image. By incorporating another scanner that slowly steers the beam along the y-axis, B-scans can be obtained at various positions in the elevational y-direction. Ultimately, the acquisition of B-scans by a pair of scanners creates an OCT data cube, representing the 3D structural information of the sample.

The second-generation OCT is known as Fourier or frequency domain OCT (FD-OCT) [32]. Unlike TD-OCT, which relies on time modulation of the OPL in the reference arm, FD-OCT utilizes the spectral information from interference signals to generate A-scans without moving the reference arm. Essentially, the broadband interference is captured spectrally in the wavelength domain. FD-OCT is categorized into 2 methods: spectral-domain OCT (SD-OCT) and swept source OCT (SS-OCT). These methods are designed to record the interference spectrum (spectral interferogram), enabling the immediate calculation of the depth scan (A-scan) through a Fourier-transform, thanks to the Fourier relation [33]. This capability substantially improves the imaging speed and signal-to-noise ratio by eliminating the need for mechanical scanning of the OPL, while maintaining image resolution.

Fig. 2A presents a schematic of an SD-OCT system, which is similar to TD-OCT; however, it features a spectrometer instead of a photodetector. This spectrometer comprises a dispersive element, such as a grating, and a line-array charge-coupled device (CCD) camera. The interference light from the fiber is dispersed by the grating into different wavelength components, which are then projected onto the line-array CCD camera. The camera captures the spectral interferogram (U), which is a composite of the spectra of all interference signals produced between each sample layer in depth and the reference arm, which is in a fixed position. Therefore, applying a fast Fourier-transform (FFT) to the spectral interferogram enables the extraction of information from the full-depth scan (A-scan).

Fig. 2.

Optical setups of Fourier-domain optical coherence tomography (OCT): spectral-domain OCT (SD-OCT) (A) and swept source OCT (SS-OCT) (B). While SD-OCT employs a spectrometer to separate the different wavelength, SS-OCT features a swept source or tunable laser, spectrally scanning single-frequency lights in time. Both implementations record a spectral interferogram encoding the reflectivity values in depth (A-scan) that can be reconstructed via fast Fourier-transform of the interference signal.

However, in SS-OCT, the spectral components are encoded by time, rather than spatial separation [34]. The setup of SS-OCT, depicted in Fig. 2B, is analogous to TD-OCT and SD-OCT systems. The key difference lies in the replacement of the broadband light source with a spectrally scanning light source capable of rapidly sweeping a very narrow line-width (<0.01 nm) across a wide range of wavelengths. This sweeping action emits successive single-frequency lights directed towards the interferometer. During a single sweep at a rate exceeding 100 kHz, interference is generated for the swept single-frequency light, allowing each wavelength component of the interference signal to be sequentially detected by a photodetector, thus reconstructing a spectral interferogram (U). Additionally, the interferogram simultaneously contains reflectivity information for all depth layers of the sample, which can be extracted by applying an FFT, resulting in a depth profile of the sample (A). For both SD- and SS-OCT systems, volumetric data acquisition is facilitated using a pair of x-y mechanical scanners.

In addition, full-field OCT (FF-OCT), a variant of ultrahigh-resolution TD-OCT, has been developed to obtain OCT images without lateral scanning [35]. Unlike TD- and FD-OCT, which focus the light beam to a single point on the sample, FF-OCT tightly focuses multiple beam spots in parallel across the sample, creating a full-field illumination effect [36]. The back-reflected light signals from the sample are detected using a 2D pixel array photodetector, such as an area CCD or CMOS camera. This approach to illumination eliminates the need for lateral mechanical scans in OCT imaging. Fig. 3A depicts a schematic of a standard FF-OCT system, which is based on a double-beam Michelson interferometer with a pair of high numerical aperture (NA) microscope objectives (referred to as a Linnik interferometer). The beam emitted from the broadband light source enters the interferometer via a Kohler illuminator, which is necessary to generate even illumination across the sample and to ensure that an image of the illumination source is not visible in the resulting CCD image [37]. The beam is then equally split by a beam splitter into 2 beams directed towards separate reference and sample arms, where they are tightly focused onto the surface of a reflector (mirror) attached to a piezo actuator and onto the sample by identical high NA (>0.3 NA) microscope objectives. Interference occurs when the OPLs between the reference arm and the sample layer in the focal plane are within the coherence length, producing an en face (x-y) interference image captured by a high-speed area CCD camera. To decode the reflectivity values at the sample layer (i.e., sample structural information) from the interference image, phase-shifting interferometry (PSI) is applied to FF-OCT. This involves varying the OPL difference by oscillating the reference mirror by a few hundred nanometers through sinusoidal motion of the piezo actuator, leading to time-varying changes in the interference signal intensities [38]. Consequently, the interference images display varying fringe patterns over time, captured by the CCD camera during a single modulation period of piezo motion. An en face (x-y) oriented tomographic image (a sample reflectivity image) is then extracted through simple arithmetic calculations between the acquired interference images [35]. Therefore, FF-OCT enables en face OCT imaging throughout the depth of tissues, achieving depths of hundreds of microns with an isotropic resolution of 1 μm or less, which is 10 times finer than the resolution of typical OCT. This high-resolution imaging technique is preferentially used to delineate microscopic tissue structures [39].

Fig. 3.

(A) A schematic of typical time-domain full-field optical coherence tomography (FF-OCT) based on a Linnik type Michelson interferometer, providing subcellular en face (x-y) tomographic imaging of live specimens. (B) A functional version of FF-OCT, named dynamic FF-OCT (D-FFOCT). D-FFOCT can provide both static information, such as cellular structure, as well as dynamic information about subcellular motility within the specimen. CCD, charge-coupled device; PZT, piezoelectric transducer.

Recent advances in FF-OCT have enabled the imaging of individual cells and their nuclei within tissue, which are not always visible in conventional FF-OCT due to significant backscattering from the surrounding tissue, a dominant component of the FF-OCT signal [40]. This method utilizes time-dependent interferometric signals modulated by the rapid motion of biological scattering elements such as nuclei, providing additional contrast correlated with subcellular metabolic activity in tissues or organs. This variant, known as dynamic FF-OCT (D-FFOCT), is achieved using the typical FF-OCT setup, where modulation of the reference arm for PSI is no longer necessary, as shown in Fig. 3B. However, the interference signal can be modulated by the movements of scatterers within the sample itself. For example, if a single scattering particle in the sample moves uniformly along the vertical axis (i.e., z-axis) within the coherence gate, the linear z-motion of the scatterer induces a displacement of the OPL in the sample arm, resulting in a time variation in the interference signal intensity (refer to Fig. 3B). By calculating the standard deviation of the interference signal over time, the dynamic signal component caused by the moving scatterers can be isolated, while the signal from highly scattering static tissue is suppressed [40]. The ability of D-FFOCT to visualize dynamics at the subcellular scale is beneficial for identifying active intracellular features at short time scales without the need for exogenous contrast agents [40,41].

3) OCT parameters

Unlike conventional microscopy, a unique advantage of OCT is that axial resolution and lateral resolution are decoupled from one another. Fig. 4 illustrates several OCT imaging parameters. The axial resolution is denoted as the resolving power to discern 2 discrete objects apartwith a difference in depth (i.e., the z-axis), which is an important imaging parameter for high-resolution OCT imaging. The axial resolution (Δz) is equivalent to the coherence length (lc) of the light source, theoretically defined as:

Fig. 4.

Schematic of a generic optical coherence tomography sample arm optics, including formulas for axial resolution, assuming it is limited by low-coherence interferometry, and for lateral resolution and depth of focus (DOF), assuming these quantities are dominated by confocal geometric optics. NA, numerical aperture.

(1) Δz=lc=2ln2π·λ02nΔλ0.44·λ02nΔλ

where λ0 and Δλ, and n are the central wavelength and the spectral bandwidth at full width at half maximum (FWHM) of the light source spectrum, and a refractive index (RI) of the sample, respectively [42]. Eq. (1) indicates that the axial resolution is fully dependent on the light source, which means that a wider spectrum ensures better axial (depth) resolution. Currently, the most commonly used light source in fiber-based OCT is a broadband superluminescent diode (SLD) with a bandwidth of up to 100 nm. With a center wavelength of 1,300 nm, the theoretical axial resolution in tissue (RI=1.4) is calculated to be 5.3 μm. Furthermore, sub-micrometer resolution can be achieved by using a much wider broadband light source at the shorter central wavelength [43]. However, the use of SLD is inappropriate for free space or parallel OCT (e.g., FF-OCT) due to its high spatial coherence [44], which generates strong speckles on the interference image due to multi-scattering induced crosstalk across the 2D pixel array of detector. Therefore, a temporally and spatially incoherent light source is imperative for free space OCT imaging, and spatiotemporally less coherent thermal light or white LED is a good choice for a light source to yield depth resolution less than 1 μm [37].

Meanwhile, the lateral resolution (Δx) of OCT, a resolving powerdefined as its ability to discern two 2 discrete objects apart in the transverse direction (x or y-axis), is equivalent to the size of the focal beam spot. This resolution adheres to the principles of conventional microscopy, which are governed by Abbe’s diffraction formula:

(2) Δx=4λπ·fd=2λπ·1NA

where f and d are the focal length of the microscope objective (OBJ) and the beam spot size, respectively. NA is the numerical aperture, a ratio of d to f. Eq. (2) indicates that the lateral resolution can be improved by increasing the NA. In other words, the use of an OBJ with a larger NA ensures better lateral resolution, although this requires a compromise with the imaging depth defined as the depth of focus, πΔx22λ.

Applications of OCT for 3D organoid imaging

The intrinsic imaging capabilities of OCT, which include non-invasiveness, non-contact, label-free, wide-field, high-resolution, and high-speed imaging, have recently been leveraged in organoid research. Since the initial application of OCT to retinal organoids in 2017 [45], it has become a prominent live imaging modality that provides insights into the structure and metabolic function of organoids during in vitro growth. In this context, we review recent studies that utilize FD-OCT and FF-OCT to explore various types of organoids. For this review, research articles published between 2017 and 2023 were examined using the global search engine Google. The search utilized 3 main keywords: optical coherence tomography, organoid imaging, and FF-OCT.

1) Retinal organoid imaging

Organoid research utilizing OCT has predominantly concentrated on retinal organoids, reflecting the common application of OCT in both ophthalmology research and clinical settings. In 2017, Browne et al. [45] pioneered the use of OCT imaging to explore structural changes in live retinal organoids throughout their development. Human pluripotent stem cell (hPSC)-derived retinal organoids replicate many aspects of embryonic retinal development, including the formation of a bi-layered optic cup and light-detecting photoreceptors [46]. These organoids are proposed as models for studying human retinal development and diseases, as well as for drug screening purposes. In their research, Browne et al. [45] employed a commercial high-resolution SD-OCT system (Spectralis; Heidelberg Engineering Inc., Carlsbad, CA, USA) to assess the microanatomic organization of hPSC-derived retinal organoids at various developmental stages. The specifications of the system include an 870 nm wavelength SLD light source, an axial resolution of 3.9 μm, a lateral resolution of 14 μm, a scanning depth of 1.9 mm, a maximum field of view (FOV) of 30×30 degrees, and a scanning speed of 40,000 A-scans per second. Additionally, the OCT system incorporates a confocal scanning laser ophthalmoscope with an 820 nm wavelength for fundus imaging. The organoids were imaged while suspended in 0.1 mL of culture media within 0.2 mL polypropylene tubes, positioned in the imaging plane of the device. Fig. 5 shows OCT images of the retinal organoid at different stages (from 46 to 151 days in culture [DIC]), revealing the maturation of the organoid [45]. For instance, OCT displays a distinct superficial hypo-reflective band (indicated by arrowheads in Fig. 5F) present at the later stage (151 DIC). This low signal band appears as a thin cellular structure, sandwiched between hyper-reflective cellular structures. The outer rim of the band is estimated to be approximately 25 μm thick, coinciding with a lamellar structure observed on histology (Fig. 5G) of the same organoid at 151 DIC.

Fig. 5.

Optical coherence tomography images of human embryonic stem cell-derived retinal organoids at 46 days in culture [DIC] (A, D), 89 DIC (B, E), and 151 DIC (C, F), showing the interior of the spheroidal retinal organoid during its development. The boxed areas in (A–C) are magnified in (D–F). In (F), a superficial hyper-reflective band (indicated by arrowheads) is seen as a boundary line. (G) A hematoxylin and eosin–stained image of the retinal organoid at 151 DIC. Scale bars: (A–C) 0.5 mm and (D–G) 0.1 mm. Modified from Browne et al. Invest Ophthalmol Vis Sci 2017;58:3311–8, according to the Creative Commons license [45].

Similar morphological alterations in retinal organoids were also identified using OCT by another research group in 2019 [47], as shown in Fig. 6. This group employed the high-resolution SD-OCT system Telesto-II from Thorlabs Inc. to monitor extensive areas of retinal organoid cultures. The 3D imaging capability of this system offers comprehensive insights into the internal anatomy and the overall shape and surface topography of the organoids. The system utilizes an SLD light source at 1300 nm with a broad spectral bandwidth (>80 nm at FWHM), achieving an imaging depth of 2.6 mm in water, with axial and lateral resolutions of 5.5 μm and 13 μm, respectively. It operates at a scanning speed of 76,000 A-scans per second. As shown in Fig. 6, OCT delineated characteristic morphological features in 3D retinal organoids during development: an open bowl-like contour for stage 1 (35 DIC) organoids (Fig. 6AC), and an enclosed spheroidal shape with a hollow core for stage 2 (54 DIC) organoids (Fig. 6DF). OCT images of stage 3 (250 DIC) organoids revealed more complex structural elements, including hair-like surface appendages and alternating high and low reflectance layers near the outer rim (Fig. 6GI), similar to the OCT images at 151 DIC (Fig. 6C and 6F). Histological images of stage 1, 2, and 3 organoids confirmed the differences in cellular stratification and interior structure implied by OCT (Fig. 6JL). Overall, OCT not only described the distinct morphological characteristics, but also uncovered additional anatomical features, distinguishing organoids from each of the 3 stages.

Fig. 6.

Optical coherence tomography (OCT) analysis of morphologically staged retinal organoids. (A–C) Stage 1 organoids (35 days in culture [DIC]): bright-field microscope image (A), 3-dimensional (3D) OCT rendering (B), and magnified OCT cross-section (C) taken from the organoid marked with an asterisk in (B). (D–F) Stage 2 organoids (54 DIC): bright-field microscope image (D), 3D OCT rendering (E), and magnified OCT cross-section (F) of the organoid marked with an asterisk in (E). (G–I) Stage 3 organoid (250 DIC): bright-field microscope image (G), 3D OCT rendering (H), and magnified OCT cross-section (I) of the organoid in (H). (J–L) Histology images of thin sections of staged organoids. Scale bars: 1 mm (A, D, G); 0.5 mm (B, C, E, H); 100 μm (F, I); 50 μm (J–L). Modified from Capowski et al. Development 2019;146:dev171686, with permission [47].

McLelland et al. [48] utilized OCT in their study on retinal organoids to explore whether sheets of hESC-derived retinal organoids could differentiate, integrate, and enhance visual function when transplanted into an immunodeficient rat model with severe retinal degeneration (RD). RD, including conditions like age-related macular degeneration, is a progressive retinopathy resulting from genetic mutations and/or environmental or pathological damage to the retina. This leads to irreversible vision loss due to the permanent loss of photoreceptors [49]. While the transplantation of fetal retinal sheets into patients with RD has been shown to improve vision, scaling this approach to a clinical level is challenging due to ethical and supply constraints. However, using sheets from retinal organoids as a transplant material may offer a scalable, effective, and safe therapeutic alternative for vision restoration in RD [50]. Therefore, the study focused on assessing the efficacy of transplanting hESC-derived retinal sheets into rats with severe RD. For the preparation of retinal sheets, RPE-free rectangular sheets measuring 1.0–1.7×0.6 mm were dissected from hESC-derived retinal organoids between days 30 and 65 of differentiation. During transplantation, a small incision was made posterior to the pars plana, and the dissected retinal organoid sheet was carefully inserted into the subretinal space of the left eye of a rat in advanced stages of RD, where most rod photoreceptors had been lost. A commercial SD-OCT system designed for preclinical research (Bioptigen Envisu R2200; Bioptigen, Durham, NC, USA) was used to monitor the transplanted rats (n=25), with imaging conducted every 1 to 2 months starting 2 weeks post-surgery and continuing up to 9.5 months. This system, optimized for posterior imaging of small animals, provides an axial resolution of less than 2 μm in tissue and an acquisition rate of 32,000 A-scans per second. Fig. 7 shows the OCT imaging result of transplant development and growth post-surgery [48]. Fig. 7A is a fundus image of the RD posterior eye with a transplant (dashed area), and representative OCT images (Fig. 7BE) in the transplant show that the retinal organoid sheets were subretinally deposited below the degenerated host retina. Notably, the formation of hyper-reflective photoreceptor rosettes, which are light-sensing structures indicated by arrows, was observed within the transplants at various days post-surgery, indicating that the transplanted sheets had differentiated, integrated, and begun functioning as photoreceptors. Additionally, improvements in visual function in the transplants were assessed using optokinetic testing and electrophysiological recording in the superior colliculus [51]. In this study, OCT proved to be a valuable tool for longitudinally monitoring the growth of human transplants derived from ESCs in vivo.

Fig. 7.

Retinal optical coherence tomography (OCT) imaging of a human embryonic stem cell–derived retinal organoid sheet transplanted into a rat eye with retinal degeneration. (A) A fundus image of the posterior eye with a transplant at 117 days post-surgery (dps). The borders of the transplant are outlined with a dashed line. (B–E) Representative retinal OCT images in the transplanted area at various dps (85 dps-160 dps), showing subretinal deposition of the transplant and its development in the degenerated host retina. The arrows in (B–E) point out photoreceptor rosettes that have formed and grown in the transplant. All scale bars: 0.2 mm. Modified from McLelland et al. Invest Ophthalmol Vis Sci 2018;59:2586–603, according to the Creative Commons license [48].

The first demonstration of FF-OCT imaging of retinal organoids was achieved by the Grieve group in 2020 [52]. They employed D-FFOCT to noninvasively capture both the structural and functional aspects of living hPSC-derived retinal organoids. This technique produced colored images with endogenous contrast related to organelle motility, featuring subcellular spatial resolution and millisecond temporal resolution. The FF-OCT system utilized in this research was a custom-built time-domain FF-OCT equipped with a broadband 660 nm LED source, achieving an axial resolution of 1.7 μm. High-magnification water-immersion objectives (40×, 0.8 NA) were used, providing a lateral resolution of 0.5 μm and a limited FOV measuring 320×320 μm2. To generate a D-FFOCT image, 512 frames of interferograms produced at the coherence gate and superimposed in the focal plane were sequentially captured by a high-speed complementary metal-oxide-semiconductor camera (Quartz 2A750; Adimec, Eindhoven, The Netherlands, operating at 750 frames per second). These frames were subsequently processed to extract local fluctuations and render them in color [52].

Fig. 8 shows D-FFOCT images of a 28-day-old (28 days post coitum [DPC]) retinal organoid culture, corresponding to the optic vesicle stage during retinogenesis [52]. Fig. 8A is a D-FFOCT image in which image brightness is linked to fluctuation amplitude (strength of organelle oscillation). Meanwhile, Fig. 8B is a colored D-FFOCT image, in which the color is linked to fluctuation speed (frequency of organelle oscillation), ranging from blue (slow) to red (fast) through green (in between). A 3D reconstruction of the organoid’s dynamics is depicted in Fig. 8C, along with a sub-volume in Fig. 8D, highlighting the layered internal organization of retinal progenitor cells (5 μm in diameter). A cross-section is shown in Fig. 8E, in which the elongated shape of cells is visible. Red arrows in the images indicate surface cells exhibiting fast dynamics. Fig. 8F presents a series of time-lapse D-FFOCT images obtained at 50 μm depth of the same organoid to examine its temporal evolution over a period of 3 hours. The images in the top row show changing cell dynamics near a clear boundary (dotted line) between 2 distinct types of cells. The cells on the right side of the boundary exhibit faster and stronger dynamics, suggesting a differentiation process towards specific retinal lineages. This work demonstrated the utility of D-FFOCT for monitoring the time course of retinal organoid developmental processes at the single-cell level, a task that has been challenging for other OCT technologies.

Fig. 8.

Dynamic full-field optical coherence tomography (D-FFOCT) imaging of human pluripotent stem cell-derived retinal organoids in culture. (A) D-FFOCT image at 50 μm depth below the surface of a spherical 28 days post coitum (DPC) retinal organoid. The brightness represents the amplitude of cell activity. (B) Pseudo-colored image of (A), in which color is linked to the frequency of cell motility. The red arrow highlights surface cells exhibiting fast dynamics. (C) Three-dimensional reconstruction of the organoid and its subvolume (D) (blue square). (E) Cross-section in (C) (green dashed line), in which the organization of the elliptical cells inside the retinal organoid is seen. (F) D-FFOCT images at the 50 μm depth of the same organoid during a 3-hour time-lapse acquisition. The images in the top row show the changes in the dynamic profile at the side of the organoid, indicating a differentiation process. The images in the bottom row show the dynamic profile in the center of the organoid, involving a very active zone composed of cells exhibiting fast and high dynamics, possibly undergoing apoptosis. Scale bars: 50 μm (A, B), 20 μm (E, F). Modified from Scholler et al. Light Sci Appl 2020;9:140, according to the Creative Commons license [52].

2) Imaging of other organoids

Since 2020, several studies have utilized OCT in research on other organoids. For example, Deloria and colleagues explored the use of OCT in analyzing human placenta-derived trophoblast organoids (TB-ORGs) [53]. These organoids, developed recently, mimic the developmental program of the early human placenta, an extraembryonic organ essential for supporting the fetus during intrauterine life. TB-ORGs offer a highly reproducible and stable in vitro model for studying not only developmental but also physiological and pathophysiological processes in early pregnancy [54,55]. The researchers aimed to use 3D OCT to investigate pathophysiological processes in placental organoids, with the objective of modeling placental diseases and enhancing understanding of fetal-maternal interactions during placentation. They hypothesized that 3D OCT could reveal the internal structures of living placental organoids without the need for sample preparation, and correlate these observations with the organoids' differentiation status. For the 3D OCT imaging, the team employed a high-resolution SD-OCT system featuring a central wavelength of 846 nm and a 3 dB bandwidth of 133.3 nm, achieving an axial resolution of 2.48 μm in the organoid tissue. The lateral resolution was also measured at 2.48 μm. OCT images were acquired at a scan speed of 5000 A-scans per second.

Fig. 9 shows OCT imaging results of TB-ORG cultures (n=3) embedded in Matrigel. Fig. 9A and 9B display bright-field microscopy and corresponding OCT cross-sections of the same TB-ORG, respectively [53]. While the bright-field microscope image barely reveals the interior of the organoid, the OCT clearly visualizes micro-cavities within the organoid, which are characteristic of the internal structure of normal TB-ORGs. Additionally, OCT has uncovered morphological differences between the control TB-ORG and the TB-ORG treated with a p38 MAPK inhibitor. This inhibitor blocks the differentiation of syncytiotrophoblasts, which is essential for hormone production and transport functions. The top row in Fig. 9C exhibits control TB-ORG samples, in which both OCT and hematoxylin and eosin (H&E)-stained images reveal the existence of cavities in the central region of the organoids. In contrast, the p38 MAPK inhibitor-treated TB-ORG (bottom row in Fig. 9C) does not exhibit these cavities, as shown in both OCT and H&E-stained images. This work suggests that OCT imaging can be routinely included in organoid research to facilitate the monitoring of in situ samples.

Fig. 9.

Optical coherence tomography (OCT) imaging of trophoblast organoids (TB-ORGs). (A) A bright-field microscope image of a TB-ORG (10 days post coitum [DPC]) and (B) a representative OCT cross-section of (A), revealing the typical micro-cavity architecture inside the normal placenta organoids. (C) A comparison between untreated (top column) and p38 inhibitor-treated (bottom column) TB-ORGs. No cavities are seen in the p38 inhibitor-treated organoid, indicating the failure of SBT differentiation. All scale bars: 100 μm. H&E, hematoxylin and eosin. SBT, syncytiotrophoblast. Adapted from Deloria et al. IEEE Trans Biomed Eng 2021;68:2368–76, according to the Creative Commons license [53].

In 2021, Gil and colleagues conducted a study using patient-derived cancer organoids (PCOs) as models for cancer drug screening [56]. They employed a custom SS-OCT system to rapidly assess both the volumetric growth and the drug response of these PCOs. The OCT system featured a swept-wavelength source from Axsun Technologies, Pittsburgh, PA, USA with a center wavelength of 1,040 nm, a bandwidth of 109 nm, and a wavelength sweeping rate of 100 kHz, which is equivalent to 100,000 A-scans per second. The system achieved axial and lateral resolutions of 6.5 μm and 16 μm, respectively. PCOs were created from 2 metastatic colorectal cancer lines derived from patients, labeled P1 and P2. These were resuspended in base medium and combined with Matrigel in a 1:1 ratio. The resulting cell-Matrigel mixture was then pipetted onto the glass surface of each well in a 24-well glass bottom plate. Over a period of 48 hours, longitudinal OCT imaging was performed using a 3D single-particle tracking technique on individual PCOs in culture. Organoid volume was subsequently estimated through quantitative analysis of the OCT data. The imaging results revealed that the application of metabolic inhibitors and cancer therapies—including cyanide, 2DG, cisplatin, and paclitaxel—to P1 and P2 led to a reduced volumetric growth rate in the PCOs compared to untreated control PCOs [56]. This study thus demonstrated the utility of OCT and 3D single-organoid tracking as effective tools for quantitatively evaluating the therapeutic impact on cancer organoids.

Very recently, Ming et al. [57] conducted a longitudinal OCT study on human heart organoids (hHOs) to characterize their morphology and motion. In the development of organoid models for human organs, hHOs have made relatively less progress due to the structural complexity of the human heart. Recently, hHOs derived from hPSCs have been developed and evaluated as a reproducible and robust in vitro model for recapitulating the human fetal heart [58,59]. The morphogenesis of heart-forming organoids is of great interest, as these organoids are expected to capture the development of heart-specific structures, including functional chambers, blood vessels, heart valves, and more. The aim of this study was to use OCT to investigate the morphogenesis of hHOs and further understand their beating patterns. The OCT setup used in this work was a customized SD-OCT system equipped with an SLD light source (SLD1325; Thorlabs Inc., Newton, NJ, USA) with a central wavelength of 1,320 nm and a spectral bandwidth of 110 nm. The axial and lateral resolutions were 4.9 μm and 7 μm, respectively, and the imaging speed was 20,000 A-scans per second. To further improve the axial resolution, the light source was replaced with a supercontinuum laser (SC450; Fianium, Bregnerodvej, Denmark) with a wavelength range from 1,175 to 1,420 nm. The broader bandwidth of the light source yielded an axial resolution of approximately 2.36 μm. OCT imaging was performed on hHO cultures daily from day 1 to day 22 and every other day from day 24 to day 30.

Longitudinal 3D OCT imaging captured dynamic morphological changes in the development of hHOs (n=32) over a 30-day period, as illustrated in Fig. 10A. Small cavities and large chambers within the hHO became visible between days 3 and 4, with their merging and enlargement observed from day 6 to day 16. Interestingly, from day 16 onward, both the number and sizes of the chambers decreased, and by day 30, the large chamber was no longer visible. However, the diameter and volume of the hHO significantly increased and plateaued starting from day 10. The development and remodeling of these chambers indicate the growth and maturation of the hHOs. Additionally, the beating of the hHO was detected through repetitive B-scans at the same location of the organoid, beginning between days 6 and 12. Fig. 10B shows a representative time series of B-scans capturing the chamber of interest during a beating cycle (contraction+relaxation). During contraction, the bottom chamber contracted and the valve-like structure (indicated by a red arrowhead) closed, and during relaxation, it reopened (Fig. 10B). The beating was quantified by measuring the distance between the upper and lower boundaries of the chamber across all frames in the time series (indicated by a red dashed box in Fig. 10B). The blue traces on the left in Fig. 10C represent the distance profiles measured from 2 heart organoids, indicating the hHOs’ beating patterns. The average beat rate was estimated to be 22.6±13.05 beats per minute (BPM), and the average interbeat interval (IBI) was 4.2±3.58 seconds for 6 hHOs. These waveforms closely resembled the typical form of calcium transients recorded from fluorescence Ca2+ imaging of the same organoids (blue traces on the right in Fig. 10C). The heart rate and IBI measured by OCT were in close agreement with those (beat rate: 22.0±7.21 BPM, IBI: 3.1±2.89 seconds) by Ca2+ imaging). These experimental results demonstrate that hHO models and OCT imaging hold significant promise for studying the human fetal heart. They provide a foundational platform for investigating human hearts at different developmental stages and exploring mechanisms of heart disease.

Fig. 10.

Longitudinal imaging of human heart organoid (hHO) culture using Optical coherence tomography (OCT). (A) OCT cross-sections of the same hHO on different days. Starting on day 4, cavities or chambers are observed within the organoid, and their size and numbers vary with the growth of the organoid. (B) hHOs’ beating characterized by OCT. During contraction, the bottom chamber shrinks, and the valve-like structure (indicated by red arrowheads) closes down between the upper and bottom channels. (C) Traces of hHOs’ beating. The blue traces on the left represent changes in the distance of the bottom chamber, measured from the red dashed box in (B). The waveforms are similar to calcium transient profiles (the blue traces on the right), recorded by fluorescence Ca2+ imaging of the same hHOs. Modified from Ming et al. Biosens Bioelectron 2022;207:114136, according to the Creative Commons license [57].

Conclusion

In summary, organoids are miniaturized and simplified in vitro models that replicate the structure and functions of actual organs. The application of organoids has surged across various fields of biological research, including growth and development, disease modeling, drug screening, cell therapy, and more. Imaging technology is an essential tool for extracting information about the structure and functions of organoids, playing a critical role in monitoring and evaluating both the culture processes of organoids and their responses to therapies. Among the array of imaging technologies, this review highlights OCT and its recent applications in the study of various organoid types, including retinal, trophoblast, cancer, and heart organoids. The OCT imaging results for these diverse organoids, as illustrated in Fig. 510, demonstrate that OCT holds significant promise as an imaging tool for longitudinal studies of live organoids. Notably, OCT does not require fixation or staining procedures that could potentially disrupt organoid structures. It enables the observation of the entire organoid body, which is typically less than 1 mm, in situ at a cellular or subcellular level. These capabilities of OCT have allowed us to observe changes in the morphology and activity of organoids using well-defined image analysis methods specifically developed for quantifying OCT datasets.

We expect that this review will be helpful for many scientists involved in the organoid community to learn about OCT and consider using it as a main imaging assay, an alternative, or a supplement to other imaging technologies for their organoid studies on single dishes [60], multi-wells [61], organoids-on-a-chip [62], and multi-organoid microfluidic systems [63], thereby providing a unique fingerprint of various organoids.

Notes

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

This research was partially supported by the Basic Science Research Program through a National Research Foundation of Korea (NRF) grant (2020R1A5A1018052) funded by the Korean government (MSIT), and a Korea Institute for Advancement of Technology (KIAT) grant (20021979) and the Technology Innovation Program (P0020967) funded by the Korean government (MOTIE).

Data availability

Please reach out to the corresponding author to inquire about the availability of data.

References

1. Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 2020;21:571–84.
2. Schutgens F, Clevers H. Human organoids: tools for understanding biology and treating diseases. Annu Rev Pathol 2020;15:211–34.
3. Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater 2021;6:402–20.
4. Nava MM, Raimondi MT, Pietrabissa R. Controlling self-renewal and differentiation of stem cells via mechanical cues. J Biomed Biotechnol 2012;2012:797410.
5. Broutier L, Andersson-Rolf A, Hindley CJ, Boj SF, Clevers H, Koo BK, et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc 2016;11:1724–43.
6. Fujii M, Matano M, Toshimitsu K, Takano A, Mikami Y, Nishikori S, et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 2018;23:787–93.
7. Scalise M, Marino F, Salerno L, Cianflone E, Molinaro C, Salerno N, et al. From spheroids to organoids: the next generation of model systems of human cardiac regeneration in a dish. Int J Mol Sci 2021;22:13180.
8. Li M, Izpisua Belmonte JC. Organoids: preclinical models of human disease. N Engl J Med 2019;380:569–79.
9. Xu H, Lyu X, Yi M, Zhao W, Song Y, Wu K. Organoid technology and applications in cancer research. J Hematol Oncol 2018;11:116.
10. Suarez-Martinez E, Suazo-Sanchez I, Celis-Romero M, Carnero A. 3D and organoid culture in research: physiology, hereditary genetic diseases and cancer. Cell Biosci 2022;12:39.
11. Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther 2022;7:168.
12. Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol 2016;18:246–54.
13. Grassi L, Alfonsi R, Francescangeli F, Signore M, De Angelis ML, Addario A, et al. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases. Cell Death Dis 2019;10:201.
14. Borten MA, Bajikar SS, Sasaki N, Clevers H, Janes KA. Automated brightfield morphometry of 3D organoid populations by OrganoSeg. Sci Rep 2018;8:5319.
15. Hradecka L, Wiesner D, Sumbal J, Koledova ZS, Maska M. Segmentation and tracking of mammary epithelial organoids in brightfield microscopy. IEEE Trans Med Imaging 2023;42:281–90.
16. Gil DA, Deming D, Skala MC. Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response. J Biomed Opt 2021;26:036005.
17. Dekkers JF, Alieva M, Wellens LM, Ariese HCR, Jamieson PR, Vonk AM, et al. High-resolution 3D imaging of fixed and cleared organoids. Nat Protoc 2019;14:1756–71.
18. Paddock SW. Principles and practices of laser scanning confocal microscopy. Mol Biotechnol 2000;16:127–49.
19. de Medeiros G, Ortiz R, Strnad P, Boni A, Moos F, Repina N, et al. Multiscale light-sheet organoid imaging framework. Nat Commun 2022;13:4864.
20. Hof L, Moreth T, Koch M, Liebisch T, Kurtz M, Tarnick J, et al. Long-term live imaging and multiscale analysis identify heterogeneity and core principles of epithelial organoid morphogenesis. BMC Biol 2021;19:37.
21. Vicente NB, Zamboni JE, Adur JF, Paravani EV, Casco VH. Photobleaching correction in fluorescence microscopy images. J Phys Conf Ser 2007;90:012068.
22. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science 1991;254:1178–81.
23. Bouma BE, de Boer JF, Huang D, Jang IK, Yonetsu T, Leggett CL, et al. Optical coherence tomography. Nat Rev Methods Primers 2022;2:79.
24. Tsai CY, Shih CH, Chu HS, Hsieh YT, Huang SL, Chen WL. Submicron spatial resolution optical coherence tomography for visualising the 3D structures of cells cultivated in complex culture systems. Sci Rep 2021;11:3492.
25. Sharma U, Chang EW, Yun SH. Long-wavelength optical coherence tomography at 1.7 microm for enhanced imaging depth. Opt Express 2008;16:19712–23.
26. Kim J, Kim S, Choi WJ. Non-invasive monitoring of cutaneous wound healing in non-diabetic and diabetic model of adult zebrafish using OCT angiography. Bioengineering (Basel) 2023;10:538.
27. Wollstein G, Schuman JS, Price LL, Aydin A, Stark PC, Hertzmark E, et al. Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol 2005;123:464–70.
28. Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007;12:051403.
29. Schmitt JM. Optical coherence tomography (OCT): a review. IEEE J Sel Top Quantum Electron 1999;5:1205–15.
30. Fercher AF. Optical coherence tomography: development, principles, applications. Z Med Phys 2010;20:251–76.
31. Leitgeb R, Hitzenberger C, Fercher A. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express 2003;11:889–94.
32. Bouma BE, Yun SH, Vakoc BJ, Suter MJ, Tearney GJ. Fourier-domain optical coherence tomography: recent advances toward clinical utility. Curr Opin Biotechnol 2009;20:111–8.
33. Izatt JA, Choma MA. Theory of optical coherence tomography. In : Drexler W, Fujimoto JG, eds. Biological and medical physics, biomedical engineering: optical coherence tomography Berlin, Heidelberg: Springer; 2008. p. 47–72.
34. Yasin Alibhai A, Or C, Witkin AJ. Swept source optical coherence tomography: a review. Curr Ophthalmol Rep 2018;6:7–16.
35. Dubois A, Grieve K, Moneron G, Lecaque R, Vabre L, Boccara C. Ultrahigh-resolution full-field optical coherence tomography. Appl Opt 2004;43:2874–83.
36. Wang L, Fu R, Xu C, Xu M. Methods and applications of full-field optical coherence tomography: a review. J Biomed Opt 2022;27:050901.
37. Vabre L, Dubois A, Boccara AC. Thermal-light full-field optical coherence tomography. Opt Lett 2002;27:530–2.
38. Dubois A. Phase-map measurements by interferometry with sinusoidal phase modulation and four integrating buckets. J Opt Soc Am A Opt Image Sci Vis 2001;18:1972–9.
39. Dalimier E, Salomon D. Full-field optical coherence tomography: a new technology for 3D high-resolution skin imaging. Dermatology 2012;224:84–92.
40. Apelian C, Harms F, Thouvenin O, Boccara AC. Dynamic full field optical coherence tomography: subcellular metabolic contrast revealed in tissues by interferometric signals temporal analysis. Biomed Opt Express 2016;7:1511–24.
41. Monfort T, Azzollini S, Brogard J, Clémençon M, Slembrouck-Brec A, Forster V, et al. Dynamic full-field optical coherence tomography module adapted to commercial microscopes allows longitudinal in vitro cell culture study. Commun Biol 2023;6:992.
42. Aumann S, Donner S, Fischer J, Müller F. Optical coherence tomography (OCT): principle and technical realization. In : Bille J, ed. High resolution imaging in microscopy and ophthalmology Cham: Springer; 2019. p. 59–85.
43. Povazay B, Bizheva K, Unterhuber A, Hermann B, Sattmann H, Fercher AF, et al. Submicrometer axial resolution optical coherence tomography. Opt Lett 2002;27:1800–2.
44. Hitzenberger CK, Danner M, Drexler W, Fercher AF. Measurement of the spatial coherence of superluminescent diodes. J Mod Opt 1999;46:1763–74.
45. Browne AW, Arnesano C, Harutyunyan N, Khuu T, Martinez JC, Pollack HA, et al. Structural and functional characterization of human stem-cell-derived retinal organoids by live imaging. Invest Ophthalmol Vis Sci 2017;58:3311–8.
46. Saha A, Capowski E, Fernandez Zepeda MA, Nelson EC, Gamm DM, Sinha R. Cone photoreceptors in human stem cell-derived retinal organoids demonstrate intrinsic light responses that mimic those of primate fovea. Cell Stem Cell 2022;29:460–71.
47. Capowski EE, Samimi K, Mayerl SJ, Phillips MJ, Pinilla I, Howden SE, et al. Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines. Development 2019;146:dev171686.
48. McLelland BT, Lin B, Mathur A, Aramant RB, Thomas BB, Nistor G, et al. Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Invest Ophthalmol Vis Sci 2018;59:2586–603.
49. Wert KJ, Lin JH, Tsang SH. General pathophysiology in retinal degeneration. Dev Ophthalmol 2014;53:33–43.
50. Lin B, McLelland BT, Aramant RB, Thomas BB, Nistor G, Keirstead HS, et al. Retina organoid transplants develop photoreceptors and improve visual function in RCS rats with RPE dysfunction. Invest Ophthalmol Vis Sci 2020;61:34.
51. Seiler MJ, Lin RE, McLelland BT, Mathur A, Lin B, Sigman J, et al. Vision recovery and connectivity by fetal retinal sheet transplantation in an immunodeficient retinal degenerate rat model. Invest Ophthalmol Vis Sci 2017;58:614–30.
52. Scholler J, Groux K, Goureau O, Sahel JA, Fink M, Reichman S, et al. Dynamic full-field optical coherence tomography: 3D live-imaging of retinal organoids. Light Sci Appl 2020;9:140.
53. Deloria AJ, Haider S, Dietrich B, Kunihs V, Oberhofer S, Knofler M, et al. Ultra-high-resolution 3D optical coherence tomography reveals inner structures of human placenta-derived trophoblast organoids. IEEE Trans Biomed Eng 2021;68:2368–76.
54. Turco MY, Gardner L, Kay RG, Hamilton RS, Prater M, Hollinshead MS, et al. Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature 2018;564:263–7.
55. Haider S, Meinhardt G, Saleh L, Kunihs V, Gamperl M, Kaindl U, et al. Self-renewing trophoblast organoids recapitulate the developmental program of the early human placenta. Stem Cell Reports 2018;11:537–51.
56. Gil DA, Deming DA, Skala MC. Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography. Biomed Opt Express 2021;12:3789–805.
57. Ming Y, Hao S, Wang F, Lewis-Israeli YR, Volmert BD, Xu Z, et al. Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography. Biosens Bioelectron 2022;207:114136.
58. Drakhlis L, Biswanath S, Farr CM, Lupanow V, Teske J, Ritzenhoff K, et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat Biotechnol 2021;39:737–46.
59. Lewis-Israeli YR, Wasserman AH, Gabalski MA, Volmert BD, Ming Y, Ball KA, et al. Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun 2021;12:5142.
60. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 2014;345:1247125.
61. Maloney E, Clark C, Sivakumar H, Yoo K, Aleman J, Rajan SA, et al. Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput. Micromachines (Basel) 2020;11:208.
62. Park SE, Georgescu A, Huh D. Organoids-on-a-chip. Science 2019;364:960–5.
63. Schuster B, Junkin M, Kashaf SS, Romero-Calvo I, Kirby K, Matthews J, et al. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat Commun 2020;11:5271.

Article information Continued

Fig. 1.

The working principle of time-domain optical coherence tomography is as follows: light from the source is split into a reference beam and a sample beam. The light that is back-reflected from both arms is recombined and recorded by the photodetector. To record one depth profile of the sample (A-scan), the reference arm needs to be axially scanned. This procedure must be repeated for each lateral scan position.

Fig. 2.

Optical setups of Fourier-domain optical coherence tomography (OCT): spectral-domain OCT (SD-OCT) (A) and swept source OCT (SS-OCT) (B). While SD-OCT employs a spectrometer to separate the different wavelength, SS-OCT features a swept source or tunable laser, spectrally scanning single-frequency lights in time. Both implementations record a spectral interferogram encoding the reflectivity values in depth (A-scan) that can be reconstructed via fast Fourier-transform of the interference signal.

Fig. 3.

(A) A schematic of typical time-domain full-field optical coherence tomography (FF-OCT) based on a Linnik type Michelson interferometer, providing subcellular en face (x-y) tomographic imaging of live specimens. (B) A functional version of FF-OCT, named dynamic FF-OCT (D-FFOCT). D-FFOCT can provide both static information, such as cellular structure, as well as dynamic information about subcellular motility within the specimen. CCD, charge-coupled device; PZT, piezoelectric transducer.

Fig. 4.

Schematic of a generic optical coherence tomography sample arm optics, including formulas for axial resolution, assuming it is limited by low-coherence interferometry, and for lateral resolution and depth of focus (DOF), assuming these quantities are dominated by confocal geometric optics. NA, numerical aperture.

Fig. 5.

Optical coherence tomography images of human embryonic stem cell-derived retinal organoids at 46 days in culture [DIC] (A, D), 89 DIC (B, E), and 151 DIC (C, F), showing the interior of the spheroidal retinal organoid during its development. The boxed areas in (A–C) are magnified in (D–F). In (F), a superficial hyper-reflective band (indicated by arrowheads) is seen as a boundary line. (G) A hematoxylin and eosin–stained image of the retinal organoid at 151 DIC. Scale bars: (A–C) 0.5 mm and (D–G) 0.1 mm. Modified from Browne et al. Invest Ophthalmol Vis Sci 2017;58:3311–8, according to the Creative Commons license [45].

Fig. 6.

Optical coherence tomography (OCT) analysis of morphologically staged retinal organoids. (A–C) Stage 1 organoids (35 days in culture [DIC]): bright-field microscope image (A), 3-dimensional (3D) OCT rendering (B), and magnified OCT cross-section (C) taken from the organoid marked with an asterisk in (B). (D–F) Stage 2 organoids (54 DIC): bright-field microscope image (D), 3D OCT rendering (E), and magnified OCT cross-section (F) of the organoid marked with an asterisk in (E). (G–I) Stage 3 organoid (250 DIC): bright-field microscope image (G), 3D OCT rendering (H), and magnified OCT cross-section (I) of the organoid in (H). (J–L) Histology images of thin sections of staged organoids. Scale bars: 1 mm (A, D, G); 0.5 mm (B, C, E, H); 100 μm (F, I); 50 μm (J–L). Modified from Capowski et al. Development 2019;146:dev171686, with permission [47].

Fig. 7.

Retinal optical coherence tomography (OCT) imaging of a human embryonic stem cell–derived retinal organoid sheet transplanted into a rat eye with retinal degeneration. (A) A fundus image of the posterior eye with a transplant at 117 days post-surgery (dps). The borders of the transplant are outlined with a dashed line. (B–E) Representative retinal OCT images in the transplanted area at various dps (85 dps-160 dps), showing subretinal deposition of the transplant and its development in the degenerated host retina. The arrows in (B–E) point out photoreceptor rosettes that have formed and grown in the transplant. All scale bars: 0.2 mm. Modified from McLelland et al. Invest Ophthalmol Vis Sci 2018;59:2586–603, according to the Creative Commons license [48].

Fig. 8.

Dynamic full-field optical coherence tomography (D-FFOCT) imaging of human pluripotent stem cell-derived retinal organoids in culture. (A) D-FFOCT image at 50 μm depth below the surface of a spherical 28 days post coitum (DPC) retinal organoid. The brightness represents the amplitude of cell activity. (B) Pseudo-colored image of (A), in which color is linked to the frequency of cell motility. The red arrow highlights surface cells exhibiting fast dynamics. (C) Three-dimensional reconstruction of the organoid and its subvolume (D) (blue square). (E) Cross-section in (C) (green dashed line), in which the organization of the elliptical cells inside the retinal organoid is seen. (F) D-FFOCT images at the 50 μm depth of the same organoid during a 3-hour time-lapse acquisition. The images in the top row show the changes in the dynamic profile at the side of the organoid, indicating a differentiation process. The images in the bottom row show the dynamic profile in the center of the organoid, involving a very active zone composed of cells exhibiting fast and high dynamics, possibly undergoing apoptosis. Scale bars: 50 μm (A, B), 20 μm (E, F). Modified from Scholler et al. Light Sci Appl 2020;9:140, according to the Creative Commons license [52].

Fig. 9.

Optical coherence tomography (OCT) imaging of trophoblast organoids (TB-ORGs). (A) A bright-field microscope image of a TB-ORG (10 days post coitum [DPC]) and (B) a representative OCT cross-section of (A), revealing the typical micro-cavity architecture inside the normal placenta organoids. (C) A comparison between untreated (top column) and p38 inhibitor-treated (bottom column) TB-ORGs. No cavities are seen in the p38 inhibitor-treated organoid, indicating the failure of SBT differentiation. All scale bars: 100 μm. H&E, hematoxylin and eosin. SBT, syncytiotrophoblast. Adapted from Deloria et al. IEEE Trans Biomed Eng 2021;68:2368–76, according to the Creative Commons license [53].

Fig. 10.

Longitudinal imaging of human heart organoid (hHO) culture using Optical coherence tomography (OCT). (A) OCT cross-sections of the same hHO on different days. Starting on day 4, cavities or chambers are observed within the organoid, and their size and numbers vary with the growth of the organoid. (B) hHOs’ beating characterized by OCT. During contraction, the bottom chamber shrinks, and the valve-like structure (indicated by red arrowheads) closes down between the upper and bottom channels. (C) Traces of hHOs’ beating. The blue traces on the left represent changes in the distance of the bottom chamber, measured from the red dashed box in (B). The waveforms are similar to calcium transient profiles (the blue traces on the right), recorded by fluorescence Ca2+ imaging of the same hHOs. Modified from Ming et al. Biosens Bioelectron 2022;207:114136, according to the Creative Commons license [57].